Anxiolytic and sedative effects of dehydroeffusol from Juncus effusus in mice

Planta Medica

Volumn 77, Issue 5, 2011, Pages 416-420

  Liao, You Jiao ^a   Zhai, Hai Feng ^b   Zhang, Bing ^a   Duan, Tian Xuan ^a   Huang, Jian Mei ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

anxiolytic; dehydroeffusol; Juncaceae; Juncus effusus; phenanthrene; sedative

Indexed keywords

ANXIOLYTIC AGENT; DEHYDROEFFUSOL; DIAZEPAM; JUNCUS EFFUSUS EXTRACT; SEDATIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; EXPERIMENTAL TEST; HOLE BOARD TEST; JUNCUS EFFUSUS; LOCOMOTION; MALE; MAZE TEST; MEDICINAL PLANT; MOUSE; NONHUMAN; OPEN FIELD TEST; ROTA ROD TEST; TRANQUILIZING ACTIVITY;

ANGIOSPERMS; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPNOTICS AND SEDATIVES; LOCOMOTION; MALE; MAZE LEARNING; MICE; PHENANTHRENES; PLANT EXTRACTS; PLANT STEMS;

JUNCACEAE; JUNCUS EFFUSUS; MUS;

EID: 79953029778     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250517     Document Type: Article

References (24)

1. Pharmacopoeia of the People's Republic of China (PPRC), English edition, Vol. 1. Beijing Chinese Ministry of Public Health 2005 168
2. Shima K, Toyota M, Asakawa Y. Phenanthrene derivatives from the medullae of Juncus effusus. Phytochemistry 1991 30 3149-3151
3. Della Greca M, Fiorentino A, Mangoni L, Molinaro A, Monaco P, Previtera L. 9,10-Dihydrophenanthrene metabolites from Juncus effusus L. Tetrahedron Lett 1992 33 5257-5260
4. Della Greca M, Fiorentino A, Molinaro A, Monaco P, Previtera L. A bioactive dihydrodibenzoxepin from Juncus effusus. Phytochemistry 1993 34 1182-1184 (Pubitemid 2012430)
5. Della Greca M, Fiorentino A, Mangoni L, Molinaro A, Monaco P, Previtera L. Cytotoxic 9, 10-dihydrophenanthrenes from Juncus effusus L. Tetrahedron 1993 49 3425-3432
6. Michela Corsaro M, della Greca M, Fiorentino A, Monaco P, Previtera L. Cycloartane glucosides from Juncus effusus. Phytochemistry 1994 37 515-519 (Pubitemid 2149354)
7. Della Greca M, Fiorentino A, Monaco P, Previtera L, Zarrelli A. Effusides I-V: 9,10-dihydrophenanthrene glucosides from Juncus effusus. Phytochemistry 1995 40 533-535
8. Jin D Z., Min Z D., Chiou G C. Y., Iinuma M, Tanaka T. Two p -coumaroyl glycerides from Juncus effusus. Phytochemistry 1996 41 545-547
9. Hanawa F, Okamoto M, Towers G H. N. Antimicrobial DNA-binding photosensitizers from the common rush, Juncus effusus. Photochem Photobiol 2002 76 51-56
10. Della Greca M, Isidori M, Lavorgna M, Monaco P, Previtera L, Zarrelli A. Bioactivity of phenanthrenes from Juncus acutus on Selenastrum capricornutum. J Chem Ecol 2004 30 867-879 (Pubitemid 39011402)
11. Li H X., Deng T Z., Chen Y, Feng H J., Yang G Z. Isolation and identification of phenolic constituents from Juncus effusus. Yao Xue Xue Bao 2007 42 174-178
12. Behery F A., Naeem Z E., Maatooq G T., Amer M M., Wen Z H., Sheu J H., Ahmed A F. Phenanthrenoids from Juncus acutus L., new natural lipopolysaccharide-inducible nitric oxide synthase inhibitors. Chem Pharm Bull (Tokyo) 2007 55 1264-1266 (Pubitemid 47344986)
13. Kovács A, Vasas A, Hohmann J. Natural phenanthrenes and their biological activity. Phytochemistry 2008 69 1084-1110
14. Calabrese E J. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate. Crit Rev Toxicol 2008 38 489-542 (Pubitemid 351962354)
15. Kirschbaum K M., Hiemke C, Schmitt U. Rotarod impairment: catalepsy-like screening test for antipsychotic side effects. Int J Neurosci 2009 119 1509-1522
16. Shiotsuki H, Yoshimi K, Shimo Y, Funayama M, Takamatsu Y, Ikeda K, Takahashi R, Kitazawa S, Hattori N. A rotarod test for evaluation of motor skill learning. J Neurosci Methods 2010 189 180-185
17. Rex A, Morgenstern E, Fink H. Anxiolytic-like effects of kava-kava in the elevated plus maze test - a comparison with diazepam. Prog Neuropsychopharmacol Biol Psychiatry 2002 26 855-860 (Pubitemid 35245552)
18. Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand J-P, Soubrié P. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci USA 2002 99 6370-6375 (Pubitemid 34493318)
19. Takeda H, Tsuji M, Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol 1998 350 21-29 (Pubitemid 28288304)
20. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003 463 3-33 (Pubitemid 36205070)
21. Davidson J R. First-line pharmacotherapy approaches for generalized anxiety disorder. J Clin Psychiatry 2009 70 (Suppl. 2) 25-31
22. Sramek J J., Zarotsky V, Cutler N R. Generalised anxiety disorder: treatment options. Drugs 2002 62 1635-1648 (Pubitemid 34848371)
23. Basile A S., Lippa A S., Skolnick P. Anxioselective anxiolytics: can less be more? Eur J Pharmacol 2004 500 441-451 (Pubitemid 39304026)
24. Fernandez S P., Mewett K N., Hanrahan J R., Chebib M, Johnston G A. R. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice. Neuropharmacology 2008 55 900-907